Crohn’s Disease and Ulcerative Colitis: Pathophysiology and New Therapeutic Strategies
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: closed (31 August 2024) | Viewed by 1185
Special Issue Editors
Interests: irritable bowel syndrome；microscopic colitis; Crohn’s disease and ulcerative colitis
Special Issues, Collections and Topics in MDPI journals
Interests: inflammatory bowel disease; coeliac disease; achalasia; screening; epidemiology; public health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue concerns the recent therapeutic developments in the management of Crohn's Disease and Ulcerative Colitis. There will be a focus on the role of the intestinal microbiome in the development of Crohn's Disease and Ulcerative Colitis, and the therapeutic place of new probiotics in the management of these conditions. The Special Issue also reflects on the place of newer biologic therapies and JAK inhibitors in the control of inflammatory process. Stem cell therapy and other new drugs targeting the inflammatory process will also be reviewed. All studies and reviews relating to the mechanisms and therapeutic strategies of Crohn's Disease are welcome.
You may choose our Joint Special Issue in Biomedicines.
Dr. Affifa Farrukh
Prof. Dr. John Mayberry
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microbiome
- probiotics
- biologics
- JAK inhibitors
- stem cell therapy
- new molecules
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
